Open an account

Xcelerate

XCRT · OTC

$0.025+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.025

About XCRT

Xcelerate, Inc. is a medical company, which engages in the provision of acquiring intellectual property technology for medical applications. The company is headquartered in Mauldin, South Carolina. The company went IPO on 2004-10-06. The firm is engaged in three separate but related businesses within the medical, health and wellness sectors. The firm is focused on the development of medical technology and virtual health services to help patients in developing countries meet their medical needs by extending the reach of physicians through the technology; the formulation, packaging and marketing of consumer health and beauty, clinically tested skin and hair care products, and owning and licensing the rights to various forms of medical equipment.

Employees
0
Headquarters
Mauldin, South Carolina
Listed
Oct 6, 2004
Sector
Health Care
Industry
Health Care Providers & Services
Website
xcelerate.global

XCRT key statistics

Market cap
5.52M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
90.59K
Volume
31.82K
Open price
$0.0249
High today
$0.0256
Low today
$0.0249
52 Week high
$0.028
52 Week low
$0.0061

Xcelerate (XCRT) at a glance

Xcelerate (XCRT) last traded at $0.025, with a market cap of 5.52M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.0249 and $0.0256. The current price is 0.4% above the day's low and 2.3% below its high.

Volume so far is 31.82K shares, below the average of 90.59K shares a day.

Over the past year Xcelerate has ranged from $0.0061 to $0.028, and now sits 86% of the way up that range.

Similar companies

Companies in the same industry as Xcelerate

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.